Franz Obermayr
Amministratore Delegato presso Panoptes Pharma GmbH
Posizioni attive di Franz Obermayr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Amministratore Delegato | 01/07/2013 | - |
| Fondatore | 01/07/2013 | - |
Storia della carriera di Franz Obermayr
Precedenti posizioni note di Franz Obermayr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Amministratore Delegato | 01/02/2021 | 26/07/2021 |
| Direttore Tecnico/Scientifico/R&S | 18/12/2020 | 31/12/2021 | |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01/01/2009 | 01/01/2013 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Austria | 2 |
| Irlanda | 2 |
Posizioni
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Settori
| Health Technology | 4 |
| Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
- Borsa valori
- Insiders
- Franz Obermayr
- Esperienza
